Pui–Chee Wu

4.0k total citations · 1 hit paper
24 papers, 3.2k citations indexed

About

Pui–Chee Wu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Pui–Chee Wu has authored 24 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Pui–Chee Wu's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). Pui–Chee Wu is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). Pui–Chee Wu collaborates with scholars based in Hong Kong, China and United States. Pui–Chee Wu's co-authors include Ching‐Lung Lai, DF Gray, Dar‐In Tai, Rong‐Nan Chien, Richard Guan, Sally L. Stephenson, Ting‐Tsung Chang, Nancy W.Y. Leung, Judy Barber and Anna S. Lok and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Pui–Chee Wu

24 papers receiving 3.1k citations

Hit Papers

A One-Year Trial of Lamivudine for Chronic Hepatitis B 1998 2026 2007 2016 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A One-Year Trial of Lamivudine for Chronic Hepatitis B
    1998 1.4k citations Ching‐Lung Lai, Rong‐Nan Chien et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pui–Chee Wu Hong Kong 16 2.6k 2.6k 569 271 228 24 3.2k
Nancy W.Y. Leung China 20 3.8k 1.4× 3.6k 1.4× 768 1.3× 300 1.1× 148 0.6× 39 4.4k
Michèle Chevallier France 22 1.8k 0.7× 1.8k 0.7× 273 0.5× 144 0.5× 295 1.3× 41 2.6k
U. Hopf Germany 31 2.5k 1.0× 2.4k 0.9× 214 0.4× 135 0.5× 204 0.9× 140 3.3k
C Pasquinelli United States 24 2.7k 1.0× 2.8k 1.1× 497 0.9× 221 0.8× 395 1.7× 37 3.5k
P. V. Holland United States 19 1.1k 0.4× 1.3k 0.5× 354 0.6× 124 0.5× 216 0.9× 36 2.1k
Shiro Iino Japan 30 2.6k 1.0× 2.7k 1.0× 252 0.4× 150 0.6× 319 1.4× 138 3.4k
Makoto Yoshiba Japan 24 1.2k 0.5× 1.1k 0.4× 239 0.4× 160 0.6× 242 1.1× 50 1.8k
Nobuhiko Hiraga Japan 31 2.2k 0.8× 2.1k 0.8× 389 0.7× 148 0.5× 465 2.0× 89 3.0k
Danny Ka‐Ho Wong Hong Kong 47 5.0k 1.9× 5.4k 2.1× 331 0.6× 236 0.9× 442 1.9× 137 6.0k
François Habersetzer France 23 1.5k 0.6× 1.3k 0.5× 401 0.7× 99 0.4× 428 1.9× 67 2.2k

Countries citing papers authored by Pui–Chee Wu

Since Specialization
Citations

This map shows the geographic impact of Pui–Chee Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pui–Chee Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pui–Chee Wu more than expected).

Fields of papers citing papers by Pui–Chee Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pui–Chee Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pui–Chee Wu. The network helps show where Pui–Chee Wu may publish in the future.

Co-authorship network of co-authors of Pui–Chee Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Pui–Chee Wu. A scholar is included among the top collaborators of Pui–Chee Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pui–Chee Wu. Pui–Chee Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuen, Man‐Fung, et al.. (2001). Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma. Cancer. 91(1). 106–112. 121 indexed citations
2.
Reiser, Markus, et al.. (2000). Induction of cell proliferation arrest and apoptosis in hepatoma cells through adenoviral-mediated transfer of p53 gene. Journal of Hepatology. 32(5). 771–782. 11 indexed citations
3.
Wong, Wai‐Man, Pui–Chee Wu, Man‐Fung Yuen, et al.. (2000). Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology. 31(1). 201–206. 178 indexed citations
4.
Lai, Ching‐Lung, Rong‐Nan Chien, Nancy W.Y. Leung, et al.. (1998). A One-Year Trial of Lamivudine for Chronic Hepatitis B. New England Journal of Medicine. 339(2). 61–68. 1427 indexed citations breakdown →
5.
Chan, Tak Mao, Pui–Chee Wu, Fu–Keung Li, et al.. (1998). Treatment of fibrosing cholestatic hepatitis with lamivudine. Gastroenterology. 115(1). 177–181. 65 indexed citations
6.
Wu, Pui–Chee, et al.. (1996). Hepatic Expression of Hepatitis B Virus Genome in Chronic Hepatitis B Virus Infection. American Journal of Clinical Pathology. 105(1). 87–95. 23 indexed citations
7.
Chan, Tak Mao, Pui–Chee Wu, Anna S. Lok, Ching‐Lung Lai, & Ignatius K.P. Cheng. (1995). Clinicopathological Features of Hepatitis C Virus Antibody Negative Fatal Chronic Hepatitis C after Renal Transplantation. ˜The œNephron journals/Nephron journals. 71(2). 213–217. 21 indexed citations
8.
Chan, Tak Mao, Pui–Chee Wu, Johnson Y.N. Lau, et al.. (1994). CLINICOPATHOLOGIC FEATURES OF HEPATITIS C VIRUS INFECTION IN RENAL ALLOGRAFT RECIPIENTS. Transplantation. 58(9). 996–1000. 23 indexed citations
9.
Wu, Pui–Chee, et al.. (1993). Relationship Between Intrahepatic Expression of Hepatitis B Viral Antigens and Histology in Chinese Patients With Chronic Hepatitis B Virus Infection. American Journal of Clinical Pathology. 100(6). 648–653. 15 indexed citations
10.
Lok, Anna S., et al.. (1992). A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology. 102(6). 2091–2097. 201 indexed citations
11.
Lai, Ching‐Lung, et al.. (1989). Synergism of chronic alcoholism and hepatitis B infection in liver disease. Journal of Gastroenterology and Hepatology. 4(1). 11–16. 16 indexed citations
12.
13.
Lai, Ching‐Lung, et al.. (1988). Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer. 62(3). 479–483. 291 indexed citations
14.
Lok, Anna S., Ching‐Lung Lai, Wai‐Mo Hui, et al.. (1987). Absence of transmission of hepatitis B by fibreoptic upper gastrointestinal endoscopy. Journal of Gastroenterology and Hepatology. 2(2). 175–180. 13 indexed citations
15.
Lok, Anna Suk‐Fong, et al.. (1987). HEPATITIS B VIRUS INFECTION IN CHINESE FAMILIES IN HONGKONG. American Journal of Epidemiology. 126(3). 492–499. 126 indexed citations
16.
Lin, Hsiang Ju, Pui–Chee Wu, & Ching‐Lung Lai. (1987). An oligonucleotide probe for the detection of hepatitis B virus DNA in serum. Journal of Virological Methods. 15(2). 139–149. 27 indexed citations
17.
Wu, Pui–Chee, et al.. (1985). Salmonella osteomyelitis: An important differential diagnosis of granulomatous osteomyelitis. The American Journal of Surgical Pathology. 9(7). 531–537. 14 indexed citations
18.
Jones, Brian M., et al.. (1985). A Case of Invasive Penicilliosis in Hong Kong with Immunologic Evaluation. American Review of Respiratory Disease. 131(4). 662–665. 46 indexed citations
19.
Wu, Pui–Chee, et al.. (1984). Quantitative morphology of mitochondria in hepatocellular carcinoma and chronic liver disease.. PubMed. 108(11). 914–6. 8 indexed citations
20.
Lin, Hsiang Ju, et al.. (1983). Phosphonoformic acid‐inhibitable nucleotide incorporation as a measure of hepatitis B viral DNA polymerase activity. Journal of Medical Virology. 12(1). 61–70. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy W.Y. Leung Breakdown of academic impact, for papers by Michèle Chevallier Breakdown of academic impact, for papers by U. Hopf Breakdown of academic impact, for papers by C Pasquinelli Breakdown of academic impact, for papers by P. V. Holland Breakdown of academic impact, for papers by Shiro Iino Breakdown of academic impact, for papers by Makoto Yoshiba Breakdown of academic impact, for papers by Nobuhiko Hiraga Breakdown of academic impact, for papers by Danny Ka‐Ho Wong Breakdown of academic impact, for papers by François Habersetzer
Rankless by CCL
2026